Synapse

← Gordon B. Mills

Papers by Gordon B. Mills

Page 7 · newest first

  1. Implementation of a Multiplex and Quantitative Proteomics Platform for Assessing Protein Lysates Using DNA-Barcoded AntibodiesMolecular & Cellular Proteomics · 2018
  2. Fallopian tube precursor lesions of serous ovarian carcinoma require L1CAM for dissemination and metastasis2018
  3. Microenvironment-Mediated Mechanisms of Resistance to HER2 Inhibitors Differ between HER2+ Breast Cancer SubtypesCell Systems · 2018
  4. Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic PipelinesCell Systems · 2018
  5. Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome AtlasCell Systems · 2018
  6. Preclinical evaluation and reverse phase protein Array-based profiling of PI3K and MEK inhibitors in endometrial carcinoma in vitroBMC Cancer · 2018
  7. Precision Oncology Decision Support: Current Approaches and Strategies for the FutureClinical Cancer Research · 2018
  8. Rab25 augments cancer cell invasiveness through a β1 integrin/EGFR/VEGF-A/Snail signaling axis and expression of fascinExperimental & Molecular Medicine · 2018
  9. Characteristics of percutaneous core biopsies adequate for next generation genomic sequencingPLoS ONE · 2017
  10. Survival of Cancer Stem-Like Cells Under Metabolic Stress via CaMK2α-mediated Upregulation of Sarco/Endoplasmic Reticulum Calcium ATPase ExpressionClinical Cancer Research · 2017
  11. Distinct histone modifications denote early stress-induced drug tolerance in cancerOncotarget · 2017
  12. Ex Vivo Confocal Fluorescence Microscopy for Rapid Evaluation of Tissues in Surgical Pathology PracticeArchives of Pathology & Laboratory Medicine · 2017
  13. A feasibility study of neoadjuvant talazoparib for operable breast cancer patients with a germline BRCA mutation demonstrates marked activitynpj Breast Cancer · 2017
  14. Physician interpretation of genomic test results and treatment selectionCancer · 2017
  15. A Comprehensive Patient-Derived Xenograft Collection Representing the Heterogeneity of MelanomaThe Medicine Forum · 2017
  16. A Population of Heterogeneous Breast Cancer Patient-Derived Xenografts Demonstrate Broad Activity of PARP Inhibitor in BRCA1/2 Wild-Type TumorsClinical Cancer Research · 2017
  17. Explore, Visualize, and Analyze Functional Cancer Proteomic Data Using the Cancer Proteome AtlasCancer Research · 2017
  18. “Personalized Cancer Therapy”: A Publicly Available Precision Oncology ResourceCancer Research · 2017
  19. Proteomic profiling of endometrioid endometrial cancer reveals differential expression of hormone receptors and MAPK signaling proteins in obese versus non-obese patientsOncotarget · 2017
  20. Precision Oncology: Neither a Silver Bullet nor a DreamPharmacogenomics · 2017
  21. Unique protein expression signatures of survival time in kidney renal clear cell carcinoma through a pan-cancer screeningBMC Genomics · 2017
  22. Comprehensive Characterization of Alternative Polyadenylation in Human CancerJNCI Journal of the National Cancer Institute · 2017
  23. Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancerNature Communications · 2017
  24. Clinical Use of Precision Oncology Decision SupportJCO Precision Oncology · 2017
  25. A Unified Approach to Targeting the Lysosome's Degradative and Growth Signaling RolesCancer Discovery · 2017
  26. ATG5 Mediates a Positive Feedback Loop between Wnt Signaling and Autophagy in MelanomaCancer Research · 2017
  27. PIK3CA exon9 mutations associate with reduced survival, and are highly concordant between matching primary tumors and metastases in endometrial cancerScientific Reports · 2017
  28. Systems analysis of apoptotic priming in ovarian cancer identifies vulnerabilities and predictors of drug responseNature Communications · 2017
  29. Integrated Genomic Characterization of Pancreatic Ductal AdenocarcinomaCancer Cell · 2017
  30. Sarcomatoid Renal Cell Carcinoma Has a Distinct Molecular Pathogenesis, Driver Mutation Profile, and Transcriptional LandscapeClinical Cancer Research · 2017
  31. Genomic analysis of exceptional responder to regorafenib in treatment-refractory metastatic rectal cancer: a case report and review of the literatureOncotarget · 2017
  32. AACR Project GENIE: Powering Precision Medicine through an International ConsortiumCancer Discovery · 2017
  33. Rational combination therapy with PARP and MEK inhibitors capitalizes on therapeutic liabilities in RAS mutant cancersScience Translational Medicine · 2017
  34. Development and Validation of an Ultradeep Next-Generation Sequencing Assay for Testing of Plasma Cell-Free DNA from Patients with Advanced CancerClinical Cancer Research · 2017
  35. Engineering and Functional Characterization of Fusion Genes Identifies Novel Oncogenic Drivers of CancerCancer Research · 2017
  36. Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome AtlasJAMA Oncology · 2017
  37. Oncogenic RAS Regulates Long Noncoding RNA Orilnc1 in Human CancerCancer Research · 2017
  38. Niche-localized tumor cells are protected from HER2-targeted therapy via upregulation of an anti-apoptotic program in vivonpj Breast Cancer · 2017
  39. Systematic characterization of A-to-I RNA editing hotspots in microRNAs across human cancersGenome Research · 2017
  40. A murine preclinical syngeneic transplantation model for breast cancer precision medicineScience Advances · 2017
  41. Epigenetic Regulation of KPC1 Ubiquitin Ligase Affects the NF-κB Pathway in MelanomaClinical Cancer Research · 2017
  42. Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcomeTyöväentutkimus Vuosikirja · 2017
  43. Randomized, placebo-controlled window trial of EGFR, Src, or combined blockade in head and neck cancerJCI Insight · 2017
  44. A feasibility study of returning clinically actionable somatic genomic alterations identified in a research laboratoryOncotarget · 2017
  45. Improved prediction of PARP inhibitor response and identification of synergizing agents through use of a novel gene expression signature generation algorithmnpj Systems Biology and Applications · 2017
  46. Identifying Abundant Immunotherapy and Other Targets in Solid TumorsThe Cancer Journal · 2017
  47. YAP/TAZ-Mediated Upregulation of GAB2 Leads to Increased Sensitivity to Growth Factor–Induced Activation of the PI3K PathwayCancer Research · 2017
  48. A patient-derived-xenograft platform to study BRCA-deficient ovarian cancersJCI Insight · 2017
  49. ALK: a tyrosine kinase target for cancer therapyMolecular Case Studies · 2017
  50. Context Specificity in Causal Signaling Networks Revealed by Phosphoprotein ProfilingCell Systems · 2016